Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)

Abstract Background Beta-blockers are commonly prescribed for patients with cardiovascular disease. Providers have been wary of treating chronic obstructive pulmonary disease (COPD) patients with beta-blockers due to concern for bronchospasm, but retrospective studies have shown that cardio-selectiv...

Descrición completa

Detalles Bibliográficos

Principais autores:	Sean Duffy, Robert Marron, Helen Voelker, Richard Albert, John Connett, William Bailey, Richard Casaburi, J. Allen Cooper, Jeffrey L. Curtis, Mark Dransfield, MeiLan K. Han, Barry Make, Nathaniel Marchetti, Fernando Martinez, Stephen Lazarus, Dennis Niewoehner, Paul D. Scanlon, Frank Sciurba, Steven Scharf, Robert M. Reed, George Washko, Prescott Woodruff, Charlene McEvoy, Shawn Aaron, Don Sin, Gerard J. Criner, the NIH COPD Clinical Research Network and the Canadian Institutes of Health Research
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2017-06-01
Series:	Respiratory Research
Assuntos:	COPD Exacerbation Beta-blocker
Acceso en liña:	http://link.springer.com/article/10.1186/s12931-017-0609-7
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!